COVID‐19: Consider IL‐6 receptor antagonist for the therapy of cytokine storm syndrome in SARS‐CoV‐2 infected patients
Chiranjib Chakraborty(Hallym University), Govindasamy Agoramoorthy(Tajen University), Manojit Bhattacharya(Fakir Mohan University), Sang‐Soo Lee(Hallym University), Ashish Ranjan Sharma(Hallym University), Garima Sharma(Integral University)
Cited by 78
Related Papers
Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine
|Molecular Therapy — Nucleic Acids|2017|727
Development of epitope‐based peptide vaccine against novel coronavirus 2019 (SARS‐COV‐2): Immunoinformatics approach
|Journal of Medical Virology|2020|424
Therapeutic advances of miRNAs: A preclinical and clinical update
|Journal of Advanced Research|2020|404
Zebrafish: A complete animal model to enumerate the nanoparticle toxicity
|Journal of Nanobiotechnology|2016|344